P. Reiss

Discipline

Sociologie (1) Economies et finances (1)

Type de document

Articles (14) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

Treatment (14) thérapie (13) Therapeutics (13) art (11) Art (11) Art (11) Art (11) art (11) Ci (Chinese poetry) (10) Patients (9) Human beings (9) Patients (9) risque (8) âge (8) Year (8) Risk (8) Confidence (8) Age (8) Age (8) Models (8) cohorte (8) mortalité (7) adulte (7) Mortality (7) Mortality (7) adulte (7) temps (durée) (6) Death (6) Rates (6) Time (6)

Documents écrit par P. Reiss (15) | parle de P. Reiss (0)

Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study.
A. Trickey et al.
Cause-specific mortality after diagnosis of cancer among HIV-positive patients: A collaborative analysis of cohort studies.
A. Trickey et al. (1 juin 2020)
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients.
F. Olearo et al.
Determinants of Restoration of CD4 and CD8 Cell Counts and Their Ratio in HIV-1-Positive Individuals With Sustained Virological Suppression on Antiretroviral Therapy.
L. Gras et al. (1 mars 2019)
Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ : CD8+ ratio.
R.A. Hughes et al. (19 juin 2018)
Increased non-AIDS mortality among persons with AIDS-defining events after antiretroviral therapy initiation.
A.C. Pettit et al.
CD4:CD8 Ratio and CD8 Count as Prognostic Markers for Mortality in Human Immunodeficiency Virus-Infected Patients on Antiretroviral Therapy: The Antiretroviral Therapy Cohort Collaboration (ART-CC).
A. Trickey et al. (15 sept. 2017)
Impact of CD4 and CD8 dynamics and viral rebounds on loss of virological control in HIV controllers.
F. Chereau et al. (2017)
Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.
N. Ngo-Giang-Huong et al. (8 nov. 2016)
Mortality According to CD4 Count at Start of Combination Antiretroviral Therapy Among HIV-infected Patients Followed for up to 15 Years After Start of Treatment: Collaborative Cohort Study.
M.T. May et al. (2016)
Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America.
M. Helleberg et al. (2015)
Impact of risk factors for specific causes of death in the first and subsequent years of antiretroviral therapy among HIV-infected patients.
S.M. Ingle et al. (2014)
Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions : D:A:D study
C.I. Hatleberg et al. (2014)
Contribution of genetic background, traditional risk factors, and HIV-related factors to coronary artery disease events in HIV-positive persons.
M. Rotger et al. (2013)
Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles?
E. Fontas et al.